Evidence map›Paper›PMID 29075063›Full record

ArticleIndian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion2017

Protective Effect of Rituximab in Chronic Graft-Versus-Host Disease Occurrence in Allogeneic Transplant patients with Epstein Barr Virus Viremia.

Shi-Meng Ji, Xie-Bing Bao, Jun Lu, Xiao Ma, Tao Tao, Ai-Ning Sun, De-Pei Wu, Sheng-Li Xue

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Shi-Meng Ji *Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.
Xie-Bing Bao *Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.
Jun Lu *Department of Hematology, Soochow University Affiliated Children's Hospital, Suzhou, China.
Xiao Ma *Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.
Tao TaoDepartment of Hematology, Loufeng Branch of the First Affiliated Hospital of Soochow University, Suzhou, China.
Ai-Ning SunDepartment of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.
De-Pei WuDepartment of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.
Sheng-Li XueDepartment of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.
First Affiliated Hospital of Soochow University · CNSoochow University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

B cells are involved in chronic graft-versus-host disease (cGVHD) pathogenesis, and Rituximab may have a therapeutic effect on cGVHD in allogeneic hematopoietic stem cell transplantation (allo-HSCT) patients. Herein, we retrospectively evaluated the prophylactic effect of Rituximab on cGVHD in a group of Chinese allo-HSCT patients. A total of 102 patients, who suffered Epstein Barr virus (EBV) viremia within 100 days after allo-HSCT, were included in this study. Fifty patients received Rituximab (375 mg/m

Indexed as

Allogeneic transplantationChronic graft-versus-host diseaseEpstein Barr virus viremiaRituximab

Identifiers

PMID29075063
PMCPMC5640536
OpenAlexW2587700278

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.